Physician‐Reported Facilitators and Barriers for Side Effect Management of Heart Failure Medications
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.033615 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Sabrina Mangal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biobehavioral Nursing and Health Informatics University of Washington School of Nursing Seattle WA USA. Hauptthemen laut MEDLINE: Heart Failure, Medication Adherence, Physician-Patient Relations. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINR NIH HHS, NCATS NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Physician underprescribing and patient nonadherence are major barriers to the benefits of guideline‐directed medical therapy. An important contributor to both underprescribing and patient nonadherence is concern about medication‐related side effects. Yet, there are few to no data on approaches used by physicians to: (1) elicit medication‐related side effects, (2) attribute these side effects to specific medications, and (3) take appropriate action. Methods and Results The authors conducted semistructured interviews with physicians to identify facilitators and barriers to each critical step of heart failure medication management: elicitation of side effects, attribution of side effects to a medication, and action in response to attributed side effects. Interviews were transcribed and coded using directed content analysis. For elicitation of potential side effects, limited patient communication and family discordance in reporting were key barriers, whereas guiding questions, measurement, and open channels of communication were key facilitators. For attribution of side effects, confounding from other medications, limited time for clinical encounters, and nonspecific symptoms were key barriers, whereas time‐limited medication discontinuation trials and medication rechallenges were key facilitators. For taking action, challenges with weighing risks and benefits and physician fear about causing harm or interfering with other clinicians were barriers, whereas patient‐physician communication and the results of a medication discontinuation trials and medication rechallenge were facilitators.
Conclusions
This study generated key facilitators and barriers to 3 key aspects of heart failure medication management related to side effects that should drive future work to improve heart failure medication management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biobehavioral Nursing and Health Informatics University of Washington School of Nursing Seattle WA USA.
- Department of Medicine Weill Cornell Medicine New York NY USA.
- Program for the Care and Study of the Aging Heart Weill Cornell Medicine New York NY USA.
ORCID-Profile: Sabrina Mangal, Maryam Hyder, Kate Zarzuela, Monika Safford, Mark Lachs, Parag Goyal
Förderung
- NIA NIH HHS
- NINR NIH HHS
- NCATS NIH HHS
Zitieren
APA
Mangal, S., Hyder, M., Mancini, J., Zarzuela, K., McDonald, W., Safford, M., Lachs, M., & Goyal, P. (2024). Physician‐Reported Facilitators and Barriers for Side Effect Management of Heart Failure Medications. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.033615
Vancouver
Mangal S, Hyder M, Mancini J, Zarzuela K, McDonald W, Safford M, et al. Physician‐Reported Facilitators and Barriers for Side Effect Management of Heart Failure Medications. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.033615
BibTeX
@article{Mangal2024,
author = {Mangal, Sabrina and Hyder, Maryam and Mancini, John and Zarzuela, Kate and McDonald, William and Safford, Monika and Lachs, Mark and Goyal, Parag},
title = {Physician‐Reported Facilitators and Barriers for Side Effect Management of Heart Failure Medications},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.033615}
}
EUVIMED